These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7339247)

  • 1. Is a functional estrogen receptor always required for progesterone receptor induction in breast cancer?
    Horwitz KB
    J Steroid Biochem; 1981 Dec; 15():209-17. PubMed ID: 7339247
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL; Katzenellenbogen BS
    Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen control of progesterone receptor induction in human breast cancer: role of nuclear estrogen receptor.
    Horwitz KB; McGuire WL
    Adv Exp Med Biol; 1979; 117():95-110. PubMed ID: 474293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptor proteins in breast cancer.
    Edwards DP; Chamness GC; McGuire WL
    Biochim Biophys Acta; 1979 Dec; 560(4):457-86. PubMed ID: 391286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
    Horwitz KB; Aiginger P; Kuttenn F; McGuire WL
    Endocrinology; 1981 May; 108(5):1703-9. PubMed ID: 7194178
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization and regulation of estrogen and progesterone receptors in breast cancer.
    Read LD; Katzenellenbogen BS
    Cancer Treat Res; 1992; 61():277-99. PubMed ID: 1360237
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen and progesterone receptor structure and action in breast cancer cells.
    Bettuzzi S; Robinson A; Fuchs-Young R; Greene GL
    Cancer Treat Res; 1992; 61():301-15. PubMed ID: 1360239
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line.
    Watson CS; Medina D; Clark JH
    Cancer Res; 1979 Oct; 39(10):4098-104. PubMed ID: 476646
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.
    Horwitz KB; McGuire WL
    J Biol Chem; 1978 Apr; 253(7):2223-8. PubMed ID: 632265
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical basis of breast cancer treatment by androgens and progestins.
    Rochefort H
    Prog Clin Biol Res; 1984; 142():79-95. PubMed ID: 6538685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormone treatment of breast cancer].
    Gröhn P
    Duodecim; 1991; 107(8):603-10. PubMed ID: 1364913
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human breast cancer: androgen action mediated by estrogen receptor.
    Zava DT; McGuire WL
    Science; 1978 Feb; 199(4330):787-8. PubMed ID: 622569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.
    Horvath G; Fernö M; Cameron R; Ranstam J
    In Vivo; 1989; 3(2):93-7. PubMed ID: 2519844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 17 beta-estradiol and progesterone activity in human breast and endometrial cancer cells by carbamate insecticides.
    Klotz DM; Arnold SF; McLachlan JA
    Life Sci; 1997; 60(17):1467-75. PubMed ID: 9126867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer.
    Pegoraro RJ; Nirmul D; Joubert SM
    Cancer Res; 1982 Nov; 42(11):4812-4. PubMed ID: 7127316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems and solutions in the evaluation of hormone receptors in breast cancer.
    Allred DC
    J Clin Oncol; 2008 May; 26(15):2433-5. PubMed ID: 18487563
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy.
    Brooks SC; Saunders DE; Singhakowinta A; Vaitkevicius VK
    Cancer; 1980 Dec; 46(12 Suppl):2775-8. PubMed ID: 7448719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.